. Analysis of β-expression in GBS isolates using rabbit anti-β serum, and analysis of hSiglec-5 binding. concentrations of ~10 9 cfu/ml. To determine the expression of protein β on the surface of the β-deletion variants of A909, a rabbit antiserum directed against the XPZ region in β was used.
Expression of the type Ia polysaccharide capsule or protein α was analysed with rabbit anti-Ia-TT and rabbit anti-α serum, respectively. A909 mutants lacking the α protein and the type Ia polysaccharide capsule (Areschoug, unpublished), respectively, were used as negative controls. Binding was detected using 125 I-labeled protein G and measured in a γ-counter. Figure S2 . Analysis of the role of the GBS polysaccharide capsule on the β-hSiglec-5 interaction.
The binding of hSiglec-5 (A), rabbit anti-β antibodies (B), and rabbit anti-Ia-TT antibodies (C) was compared between the A909 wt strain and its isogenic acapsular mutant (Δcap), β-negative mutant (Δbac) and double mutant (Δbac/Δcap). The Δcap and double mutants were constructed by inactivation of the cpsIaE gene, which encodes a glycosyltransferase, resulting in mutants lacking the entire polysaccharide capsule (Areschoug, unpublished) . Overnight cultures were washed and resuspended to a final concentration of ~10 9 cfu/ml. After incubation with hSiglec-5 or rabbit antiserum, bacteria were washed and binding was detected using 125 I-labeled protein G measuring the radioactivity associated with the bacterial pellet in a γ-counter.
